Secondary lymphomas of the skin

Alessandro Pileri; Lidia Sacchelli; Marina Mussi; Stephano Cedirian

doi:10.4081/dr.2023.9743

Authors

Alessandro Pileri
alessandro.pileri2@unibo.it
Dermatology Unit, S. Orsola-Malpighi Hospital, Bologna; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Italy. https://orcid.org/0000-0002-1025-7171
Lidia Sacchelli Dermatology Unit, S. Orsola-Malpighi Hospital, Bologna; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Italy.
Marina Mussi Dermatology Unit, S. Orsola-Malpighi Hospital, Bologna; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Italy.
Stephano Cedirian Dermatology Unit, S. Orsola-Malpighi Hospital, Bologna; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Italy. https://orcid.org/0000-0002-9783-7864

Infection of the skin may be the result of an underlying disease, or lymphoma may be the primary cause. As a result, it is possible to differentiate between two types of lymphomas: primary cutaneous lymphoma and secondary cutaneous lymphoma (SCL), which is a type of systemic lymphoma that also affects the skin. The objective of the current review is to examine what is currently known about this neglected subject. Following this, SCL was examined from a clinical, histological, and survival perspective.

Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-85.

Fava P, Roccuzzo G, Alberti-Violetti S, et al. Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management. Presse Med 2022;51:104109.

Pileri A, Guglielmo A, Grandi V, et al. The microenvironment’s role in mycosis fungoides and Sézary syndrome: from progression to therapeutic implications. Cells 2021;10:2780.

Grandi V, Baldo A, Berti E, et al. Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus. Photodermatol Photoimmunol Photomed 2021;37:334-42.

Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009;113:5064-73.

Fujita A, Hamada T, Iwatsuki K. Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008. J Dermatol 2011;38:524-30.

Yasukawa K, Kato N, Kodama K, et al. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification. J Cutan Pathol 2006;33:487-91.

Park JH, Shin HT, Lee DY, et al. World Health Organization- European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution. J Am Acad Dermatol 2012;67:1200-9.

Lee WJ, Won KH, Won CH, et al. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage. Br J Dermatol 2015;173:134-45.

Kastnerova L, Belousova IE, Hadravsky L, et al. Mummified cells are a common finding in cutaneous Hodgkin lymphoma and can be used as a diagnostic clue. Am J Dermatopathol 2020;42:24-8.

Cerroni L, Beham-Schmid C, Kerl H. Cutaneous Hodgkin’s disease: an immunohistochemical analysis. J Cutan Pathol 1995;22:229-35.

Gru AA, Bacchi CE, Pulitzer M, et al. Secondary skin involvement in classic Hodgkin lymphoma: Results of an international collaborative cutaneous lymphoma working group study of 25 patients. J Cutan Pathol 2021;48:1367-78.

Maher NG, Chiang YZ, Badoux X, et al. Saggy skin as a presenting sign of angioimmunoblastic T-cell lymphoma. Clin Exp Dermatol 2016;41:386-9.

Wang L, Lee HY, Koh HY, et al. Cutaneous Presentation of Angioimmunoblastic T-Cell Lymphoma: A Harbinger of Poor Prognosis? Skinmed 2016;14:469-71.

Pileri A, Cricca M, Gandolfi L, et al. Vemurafenib mucosal side-effect. J Eur Acad Dermatol Venereol 2016;30:1053-5.

La Placa M, Bacci F, Gurioli C, et al. Erythematous induration of the chest. J Dtsch Dermatol Ges 2015;13:1291-3.

Massone C, Lozzi GP, Egberts F, et al. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat. J Cutan Pathol 2006;33:418-25.

Pujol RM, Gallardo F, Servitje O, et al. Peripheral T-cell lymphoma with secondary epithelioid granulomatous cutaneous involvement: a clinicopathologic study of four cases. J Dermatol 2005;32:541-8.

Sánchez-Romero C, Bologna-Molina R, Paes de Almeida O, et al. Extranodal NK/T cell lymphoma, nasal type: An updated overview. Crit Rev Oncol Hematol 2021;159:103237.

Yu X, Zhang J, Xu K, et al. Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma. Clin Exp Dermatol 2017;42:539-42.

Hoshina D, Arita K, Mizuno O, et al. Skin involvement in ALK-negative systemic anaplastic large-cell lymphoma. J Am Acad Dermatol 2012;67:e159-60.

Cho YR, Seo JW, Oh SY, et al. The expressions of MUM-1 and Bcl-6 in ALK-negative systemic anaplastic large cell lymphoma with skin involvement and primary cutaneous anaplastic large cell lymphoma. Int J Clin Exp Pathol 2020;13:1682-7.

Dittus C, Sloan JM. Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home. Hematol Oncol Clin North Am 2017;31:255-72.

Yamaguchi T, Ohshima K, Karube K, et al. Clinicopathological features of cutaneous lesions of adult Tcell leukaemia/ lymphoma. Br J Dermatol 2005;152:76-81.

Marchetti MA, Pulitzer MP, Myskowski PL, et al. Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study. J Am Acad Dermatol 2015;72:293-301.

Miyashiro D, Sanches JA. Cutaneous manifestations of adult T-cell leukemia/lymphoma. Semin Diagn Pathol 2020;37:81-91.

Vila-Payeras A, Terrasa-Sagristá F, Nadal-Lladó C, Parera-Amer E. Systemic B-cell lymphoma with skin manifestation clinically resembling granuloma annulare. J Cutan Pathol 2021;48:607-10

Dhadlie S, Strekozov B. Cutaneous extra nodal lymphoma relapse: A case report and review of literature. Int J Surg Case Rep 2018;51:306-8.

Hoefnagel JJ, Vermeer MH, Jansen PM, et al. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol 2003;149:1183-91.

Pileri A, Grandi V, Agostinelli C, et al. BCL-2 expression in primary cutaneous follicle center lymphoma is associated with a higher risk of cutaneous relapses: A study of 126 cases. J Eur Acad Dermatol Venereol 2022;36:e811-e813.

Kim BK, Surti U, Pandya A, et al. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas. Am J Surg Pathol 2005;29:69-82.

Gerami P, Wickless SC, Querfeld C. Cutaneous involvement with marginal zone lymphoma. J Am Acad Dermatol 2010;63:142-5.

Moretti S, Pimpinelli N, Di Lollo S, et al. In situ immunologic characterization of cutaneous involvement in Hodgkin’s disease. Cancer 1989;63:661-6.

Kim BK, Surti U, Pandya AG, Swerdlow SH. Primary and secondary cutaneous diffuse large B-cell lymphomas: a multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation. Am J Surg Pathol 2003;27:356-64.

Lee WJ, Won KH, Won CH, et al. Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type. Acta Derm Venereol 2016;96:245-50.

Pileri, A., Sacchelli, L., Mussi, M., & Cedirian, S. (2023). Secondary lymphomas of the skin. Dermatology Reports, 16(s2). https://doi.org/10.4081/dr.2023.9743